共 136 条
[1]
Grant RM(2010)Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 2587-2599
[2]
Lama JR(2013)Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomized, double-blind, placebo-controlled phase 3 trial The Lancet 381 2083-2090
[3]
Anderson PL(2012)Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N Engl J Med 367 399-410
[4]
McMahan V(2012)Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana N Engl J Med 367 423-434
[5]
Liu AY(2013)Efficacy of pre-exposure prophylaxis for HIV-1 prevention among high risk heterosexuals: subgroup analyses from a randomized trial AIDS 27 2155-2160
[6]
Vargas L(2014)HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention J Acquir Immune Defic Syndr 66 340-348
[7]
Choopanya K(2015)Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition—United States, 2015 MMWR Morb Mortal Wkly Rep 64 1291-1295
[8]
Martin M(2012)Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study PLoS ONE 7 e28238-829
[9]
Suntharasamai P(2015)Knowledge, attitudes, and experiences of HIV pre-exposure prophylaxis (PrEP) trial participants in Botswana World J AIDS 5 10-477
[10]
Sangkum U(2014)Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study Lancet Infect Dis. 14 820-691